NCT00864526View on ClinicalTrials.gov

A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Healthy
Interventions
DRUG

Oxycodone HCl 5 mg / Ibuprofen 400 mg tablets, single dose

A: Experimental SSubjects received Actavis formulated products under fasting conditions

DRUG

COMBONOX® tablets, single dose

B: Active comparator Subjects received Forest Pharmaceuticals, Inc formulated products under fasting conditions

Trial Locations (1)

63301

Gateway Medical Research, Inc, Saint Charles

Sponsors

Lead Sponsor

Actavis Inc.
All Listed Sponsors
lead

Actavis Inc.

INDUSTRY

NCT00864526 - A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter